Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-17 of 17 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patients.
Hansen-Abeck I, Geidel G, Abeck F, Kött J, Cankaya R, Dobos G, Mitteldorf C, Nicolay JP, Albrecht JD, Menzer C, Livingstone E, Mengoni M, Braun AD, Wobser M, Klemke CD, Tratzmiller S, Assaf C, Terheyden P, Klespe KC, [...] Booken N
J Dtsch Dermatol Ges, 22(11):1489-1497, 02 Oct 2024
Cited by: 0 articles | PMID: 39358932
Add to export list
Differential predictive value of tissue-specific PD-L1 expression scores in adjuvant immunotherapy of melanoma.
Geidel G, Parnian N, Meß C, Schlepper N, Rünger A, Heidrich I, Hansen I, Smit DJ, Menz A, Pantel K, Schneider SW, Kött J, Gebhardt C
J Eur Acad Dermatol Venereol, 38(10):2017-2023, 15 Jun 2024
Cited by: 0 articles | PMID: 38877773
Add to export list
High Serum Levels of CCL20 Are Associated with Recurrence and Unfavorable Overall Survival in Advanced Melanoma Patients Receiving Immunotherapy.
Kött J, Hoehne IL, Heidrich I, Zimmermann N, Reese KL, Zell T, Geidel G, Rünger A, Schneider SW, Pantel K, Smit DJ, Gebhardt C
Cancers (Basel), 16(9):1737, 29 Apr 2024
Cited by: 1 article | PMID: 38730689 | PMCID: PMC11083498
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy.
Kött J, Zimmermann N, Zell T, Rünger A, Heidrich I, Geidel G, Smit DJ, Hansen I, Abeck F, Schadendorf D, Eggermont A, Puig S, Hauschild A, Gebhardt C
Eur J Cancer, 202:113989, 08 Mar 2024
Cited by: 0 articles | PMID: 38518535
Add to export list Review
C-reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma.
Kött J, Zimmermann N, Zell T, Heidrich I, Geidel G, Rünger A, Smit DJ, Merkle M, Parnian N, Hansen I, Hoehne I, Abeck F, Torster L, Weichenthal M, Pantel K, Schneider SW, Gebhardt C
J Eur Acad Dermatol Venereol, 38(8):1575-1587, 11 Mar 2024
Cited by: 0 articles | PMID: 38466133
Add to export list
Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma.
Hansen I, Rünger A, Noebel C, Geidel G, Kött J, Menz A, Hildebrandt L, Schneider SW, Gebhardt C
J Eur Acad Dermatol Venereol, 38(9):e820-e822, 29 Feb 2024
Cited by: 0 articles | PMID: 38421077
Add to export list
Sepsis-like cytokine release syndrome after application of tebentafusp in metastasized uveal melanoma.
Geidel G, Abeck F, Hansen I, Kött J, Heidrich I, Rünger A, Hildebrandt L, Gebhardt C
J Eur Acad Dermatol Venereol, 38(6):e473-e475, 07 Dec 2023
Cited by: 0 articles | PMID: 38059699
Add to export list
Neoadjuvant cemiplimab induces durable complete response in locally advanced cutaneous squamous cell carcinoma.
Geidel G, Adam L, Rünger A, Menz A, Kött J, Haalck T, Gebhardt C
J Eur Acad Dermatol Venereol, 37(12):e1414-e1416, 24 Jul 2023
Cited by: 3 articles | PMID: 37458533
Add to export list
Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors.
Stadler JC, Keller L, Mess C, Bauer AT, Koett J, Geidel G, Heidrich I, Vidal-Y-Sy S, Andreas A, Stramaglia C, Sementsov M, Haberstroh W, Deitert B, Hoehne IL, Reschke R, Haalck T, Pantel K, Gebhardt C, Schneider SW
J Immunother Cancer, 11(5):e006456, 01 May 2023
Cited by: 2 articles | PMID: 37258039 | PMCID: PMC10255197
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in Melanoma.
Ammann NL, Schwietzer YF, Mess C, Stadler JC, Geidel G, Kött J, Pantel K, Schneider SW, Utikal J, Bauer AT, Gebhardt C
Cancers (Basel), 14(22):5676, 18 Nov 2022
Cited by: 5 articles | PMID: 36428768 | PMCID: PMC9688620
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
IFNA pathway drives the more aggressive phenotype of KRAS^G12D-mutant pancreatic ductal adenocarcinomas via IFNAR1/STAT3 activation
Inoue K, Schanne DH, Matsui A, Lei P, Klein S, Aoki S, Taniguchi H, Kikuchi H, Chen J, Liu Z, Tsai SQ, Schmidt TC, Iwasaki M, Geidel G, Koch A, Huang P, Fukumura D, Shioda T, Munn LL, [...] Duda DG
bioRxiv, 01 Jul 2022
Cited by: 0 articles | PPR: PPR512258
Add to export list Preprint
Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma.
Geidel G, Heidrich I, Kött J, Schneider SW, Pantel K, Gebhardt C
NPJ Precis Oncol, 6(1):17, 23 Mar 2022
Cited by: 3 articles | PMID: 35322182 | PMCID: PMC8943023
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Value of cemiplimab in progressive metastatic cutaneous squamous cell carcinoma after kidney transplantation: a case report.
Geidel G, Rünger A, Schneider SW, Gebhardt C
J Eur Acad Dermatol Venereol, 36 Suppl 1:49-52, 01 Jan 2022
Cited by: 1 article | PMID: 34855252
Add to export list
Adjuvante Pembrolizumab-assoziierte Hyperprogression eines Melanoms im Stadium III.
Ammann NL, Geidel G, Schneider SW, Gebhardt C
J Dtsch Dermatol Ges, 19(9):1341-1345, 01 Sep 2021
Cited by: 1 article | PMID: 34541804
Add to export list
Hyperprogression fortgeschrittener Melanomerkrankung unter Pembrolizumab adjuvant.
Geidel G, Ammann NL, Schneider SW, Gebhardt C
J Dtsch Dermatol Ges, 19 Suppl 1:37-39, 01 Jul 2021
Cited by: 0 articles | PMID: 33835653
Add to export list
Adjuvant pembrolizumab-related hyperprogression in stage III melanoma.
Ammann NL, Geidel G, Schneider SW, Gebhardt C
J Dtsch Dermatol Ges, 19(9):1341-1345, 13 Jul 2021
Cited by: 0 articles | PMID: 34255418
Add to export list
Enrichments of Metals, Including Methylmercury, in Sewage Spills in South Carolina, USA.
Emmons AM, Bizimis M, Lang SQ, Stangler W, Geidel G, Baalousha M, Wanamaker E, Rothenberg SE
J Environ Qual, 47(5):1258-1266, 01 Sep 2018
Cited by: 3 articles | PMID: 30272795 | PMCID: PMC7372966
Add to export list Free full text in Europe PMC

1-17 of 17 results

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patients.

Differential predictive value of tissue-specific PD-L1 expression scores in adjuvant immunotherapy of melanoma.

High Serum Levels of CCL20 Are Associated with Recurrence and Unfavorable Overall Survival in Advanced Melanoma Patients Receiving Immunotherapy.

Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy.

C-reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma.

Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma.

Sepsis-like cytokine release syndrome after application of tebentafusp in metastasized uveal melanoma.

Neoadjuvant cemiplimab induces durable complete response in locally advanced cutaneous squamous cell carcinoma.

Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors.

Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in Melanoma.

IFNA pathway drives the more aggressive phenotype of KRAS^G12D-mutant pancreatic ductal adenocarcinomas via IFNAR1/STAT3 activation

Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma.

Value of cemiplimab in progressive metastatic cutaneous squamous cell carcinoma after kidney transplantation: a case report.

Adjuvante Pembrolizumab-assoziierte Hyperprogression eines Melanoms im Stadium III.

Hyperprogression fortgeschrittener Melanomerkrankung unter Pembrolizumab adjuvant.

Adjuvant pembrolizumab-related hyperprogression in stage III melanoma.

Enrichments of Metals, Including Methylmercury, in Sewage Spills in South Carolina, USA.

Partnerships & funding